JW Pharmaceutical (XKRX:001065.PFD) FCF Margin % : 5.84% (As of Dec. 2024)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. JW Pharmaceutical's Free Cash Flow for the three months ended in Dec. 2024 was ₩10,963.40 Mil. JW Pharmaceutical's Revenue for the three months ended in Dec. 2024 was ₩187,851.18 Mil. Therefore, JW Pharmaceutical's FCF Margin % for the quarter that ended in Dec. 2024 was 5.84%.

As of today, JW Pharmaceutical's current FCF Yield % is 9.85%.

The historical rank and industry rank for JW Pharmaceutical's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of JW Pharmaceutical was 8.77%. The lowest was -3.06%. And the median was 6.35%.

XKRX:001065.PFD's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.755
* Ranked among companies with meaningful FCF Margin % only.

JW Pharmaceutical FCF Margin % Historical Data

The historical data trend for JW Pharmaceutical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical FCF Margin % Chart

JW Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

8.77

0.86

6.49

6.21

7.12

JW Pharmaceutical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															11.91	17.06	4.65	0.83	5.84

Competitive Comparison of JW Pharmaceutical's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW Pharmaceutical's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where JW Pharmaceutical's FCF Margin % falls into.

Save Embed

;

Save Embed

;

JW Pharmaceutical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

JW Pharmaceutical's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	51254.301	/	719375.756
	=	7.12 %

JW Pharmaceutical's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	10963.401	/	187851.177
	=	5.84 %

JW Pharmaceutical FCF Margin % Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001065.PFD) » Definitions » FCF Margin %

Traded in Other Exchanges

001067:Korea 001060:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines